Leadership

  

Links

George Carpenter, Chief Executive Officer

George Carpenter is a results-oriented executive with a passion for leading high growth and turnaround companies. As Chief Executive Officer of CNS Response, Inc., George is leading the commercialization of the company’s patented Referenced-EEG technology for psychiatric medication management. Before joining CNS Response Inc., George ran WorkWell Systems Inc., an international physical medicine firm and 2004 winner of the ABL Innovation in Healthcare Award. From 1990 to 2002, George served as Chairman and CEO of CORE, Inc., (Nasdaq: CORE) after leading the management buyout of this division of Baxter Healthcare. A finalist in the E&Y Entrepreneur of the Year program, Carpenter led CORE to a record of clinical software innovation and business development that, in the words of one Wall Street analyst, "created an industry". CORE was acquired in 2001 by Assurant Inc. George was a Vice President of Operations with Baxter Healthcare before founding CORE. His career began at Inland Steel in manufacturing process control and Sales. Serving on various biomedical advisory and fiduciary boards, he is a frequent speaker and writer on healthcare technology and financing issues. His book "The Shape of Things" (LRP Publications, 2006) focused on the neurochemistry of obesity and its impact on the American workforce. He holds an MBA in Finance from the University of Chicago and a BA with Distinction in International Policy & Law from Dartmouth College.

 

Daniel A. Hoffman, M.D., President and Chief Medical Officer

Daniel Hoffman, MD is a Neuropsychiatrist with over 25 years experience treating general psychiatric conditions such as depression, bipolar disorder and anxiety. He provides the newest advances in diagnosing and treating attentional and learning problems in children and adults. Dr. Hoffman has authored over 40 professional articles, textbook chapters, poster presentations and letters to the editors on various aspects of neuropsychiatry, Quantitative EEG, LORETA, Referenced EEG, advances in medication management, national position papers and standards, Mild Traumatic Brain Injury, neurocognitive effects of Silicone Toxicity, sexual dysfunction and other various topics. Dr. Hoffman has given over 58 major presentations and seminars, including Grand Rounds at Universities and Hospitals, workshops and presentations at national society meeting (such as American Psychiatric Association and American Neuropsychiatric Association), national CME conferences, insurance companies, national professional associations, panel member discussant, and presenter of poster sessions. Dr Hoffman has a Bachelor of Science in Psychology from the University of Michigan, an MD from Wayne State University School of Medicine and conducted his Residency in Psychiatry from the University of Colorado Health Sciences Center.

 

Mark Desrosiers, Senior Vice President Commercial Operations

Mark Desrosiers brings over 17 years of technology and strategy experience with business-to-business and business-to-consumer organizations. Mr. Desrosiers has extensive experience in applying technology solutions to explore and develop new business opportunities. Prior to joining CNS Response, Mr. Desrosiers was Senior Vice President of Product Development for WorkWell Systems, the leading provider of physical medicine solutions. Prior to joining WorkWell Systems, Mr. Desrosiers served as Vice President of Professional Services for Dimension Data North America and was the Managing Director of Dimension Data’s Healthcare and Pharmaceutical business unit. He focused extensively on advising and delivering innovative technology solutions for leading Fortune 500 companies and other forward thinking businesses. In his role, he was responsible for providing management and leadership to the Healthcare and Pharmaceutical business unit, one of Dimension Data’s fastest growing vertically oriented consulting teams. Leading clients include: The Advisory Board Company, AstraZeneca, Bayer, Health Scribe, Johnson & Johnson, McKesson Corporation, Delta Dental, Group Health Incorporated, WellPoint Health Networks and AARP. Mr. Desrosiers has also held senior-level management positions in a number of healthcare service organizations, including the position of Director of Product Development at MedAmerica, a national medical services organization where he directed application development and business strategy efforts for business-critical clinical and process management initiatives. Mr. Desrosiers graduated from the University of Maine with a B.S. in Marketing Communications, with a concentration in Advertising.

 

Brian MacDonald, Chief Engineer

Prior to receiving his MBA from Wharton in 1990, Brian MacDonald was trained in operations and chemical engineering. He consulted for Deloitte & Touche Management Consulting, KPMG Strategic Services and in private practice. His focus throughout this time was in the area of operations and information systems. He is co-founder of Mill City Venture Development that consulted for the predecessor company to CNS Response. In addition to his work in organizing operations, Mr. MacDonald has led the development of the rEEG® automated statistical report generator and the CNS Response managed care economic simulation and analysis software.


Ken Graap, Director of Network Services

Ken Graap is Director of Network Services at CNS Response Inc. As Director of Network Services, Ken develops and oversees outreach and education for professionals interested in applying rEEG? in their professional work. Ken comes to CNS Response after serving as the CEO of Virtually Better, Inc. (Decatur, GA). As CEO, he successfully headed the development and marketing of Virtual Reality systems for use in health and health related applications. Ken received his undergraduate degree in Technical Management with a minor in Economics from Regis University, a Masters degree in Education Psychology from the University of Alberta. He completed 4 years of doctoral work in Clinical Psychology from Emory University and a clinical internship at the Atlanta VA. Ken worked for 5 years at Lexicor Medical Technology, a manufacturer of Quantitative EEG equipment. Ken currently resides in Atlanta, GA with his wife, Kay and their 6 year old daughter, Kyra who is in kindergarten. When not working, he enjoys playing golf, outdoor activities, and traveling.


Michael Metzig, Manager of Laboratory Services

Michael Metzig has a thorough knowledge of laboratory testing and laboratory operations working for 10 years with Westcliff Medical Laboratories, Inc, (Southern California's largest independently owned medical laboratory). He started the Client Service Department, headed the Quality Assurance Team, co-chaired the Safety Committee, and was the company's Compliance Officer (writing the corporate compliance manual). He also managed the Phlebotomy Department and wrote the phlebotomy procedure manual. His experience in automated and manual laboratory analysis and CLIA regulations is directly applicable to the rEEG production laboratory.


Mark Schiller, MD

Dr. Schiller is an Assistant Clinical Professor in Psychiatry at UCSF and received his medical and psychiatric training at The University of Chicago, Yale University, and UCSF. He has been involved with business development and strategic relationships for three early stage ventures. He is a frequent speaker on TV and radio and is the author of numerous articles on healthcare economics and policy in his role as President of the Association of American Physicians and Surgeons and as Senior Fellow in Medical Studies at the Pacific Research Institute. Dr. Schiller’s areas of responsibility include research, facets of clinical operations, and business development.


Meyer Proler, M.D., President, University Neurodiagnostics

Through his telemedicine practice Dr. Proler is believed to be the largest provider of traditional EEG analysis in the US. Dr. Proler supports the company in providing neurological review and qualification of EEG files prior to rEEG analysis.

 

> Leadership

> Board of Directors

> Scientific Advisory Board
 
Copyright 2010 CNS Response